In an effort to foster stronger partnerships with international entities and the UAE in the realms of education, healthcare, and research, Burjeel Holdings, a prominent provider of super-specialty healthcare services in the MENA region, has unveiled the Burjeel Institute for Global Health in the United States. The institute's inception was celebrated with a series of high-profile discussions centered on advancements in cancer care and technology, featuring an array of international experts.
The launch ceremony was attended by Dr. Thani bin Ahmed Al Zeyoudi, the UAE Minister of State for Foreign Trade, who highlighted the UAE's commitment to advancing healthcare through collaborative research and education with global partners. He emphasized the importance of R&D partnerships, the adoption of best practices in UAE hospitals, and investments in technology to bolster capabilities. Addressing the challenge of cancer, Dr. Al Zeyoudi expressed the UAE's resolve to develop life-saving solutions that offer stability to families and hope to children fighting the disease, underscoring the need for a comprehensive approach involving the private sector, academia, regulators, and NGOs.
Dr. Al Zeyoudi expressed optimism that the Burjeel Institute for Global Health would serve as a focal point for pioneering research, treatment, drug development, and care, promoting partnerships through knowledge exchange and best practice implementation. The establishment of the institute by the UAE-based healthcare group is aimed at enhancing its global reach for talent and academic excellence, enabling the recruitment of leading researchers, scientists, and medical professionals, thereby strengthening Burjeel's clinical and research capabilities and its status as a global healthcare leader.
Dr. Shamsheer Vayalil, founder and chairman of Burjeel Holdings, noted the significance of opening the Burjeel Institute for Global Health in New York, stating that it would enhance international contributions and facilitate collaborations with top healthcare institutions and companies. The goal is to advance medical treatments and technologies to improve global health outcomes.
The launch event also included discussions on the latest healthcare advancements and policies, featuring speakers such as Dr. Ashwin Vasan, Dr. Ophira Ginsburg, Dr. Chitkala Kalidas, Mike Sicilia, and Dr. Vayalil. Topics ranged from local initiatives like New York State's proposed bill on colorectal cancer screening coverage to innovative financing mechanisms for cancer combat. The future of oncology care was a key focus, with an emphasis on equitable access and the need for global adaptation of innovative practices. Discussions also touched on the development of AI-interpretable clinical data, leveraging large language models trained on multimodal data to improve AI accuracy in cancer diagnostics and drug development, aligning with the broader objective of transforming cancer treatment through advanced technologies.
Through its New York office, Burjeel Holdings intends to solidify its role as a pivotal player in global healthcare, driving health outcomes enhancement through innovative international collaborations.
